MEDICINES
PATIENT ASSISTANCE PROGRAMS
IMPORTED MEDICINES
CONTACT US
Upload
Introduction to Viganext 500mg Sachet
Viganext 500mg Sachet is an antiepileptic medication containing the active ingredient Vigabatrin. It belongs to a class of drugs known as anticonvulsants. This medicine is used to treat various forms of epilepsy, particularly when current medications are not effectively controlling seizures. Additionally, it is used to manage infantile spasms, also known as West’s syndrome.
Do not take Viganext 500mg Sachet if you are allergic to Vigabatrin or any of its ingredients. Before starting treatment, inform your physician if you have or have had depression, any other psychiatric illnesses, kidney problems, or eye conditions. It’s crucial to notify your doctor if you are pregnant, planning to become pregnant, think you may be pregnant, or are breastfeeding. This medicine may cause decreased eyesight due to issues like retinal disorder, blurry vision, optic atrophy, or optic neuritis. If you notice any changes in your vision, it’s important to consult an eye specialist promptly.
Uses of Viganext 500mg Sachet
- Uncontrolled epilepsy
- Infantile spasms
Therapeutic Effects of Viganext 500mg Sachet
Viganext 500mg Sachet works by increasing the levels of a calming neurotransmitter called GABA in the brain. It achieves this by inhibiting an enzyme that breaks down GABA, which in turn reduces nerve cell activity and helps prevent seizures.
Interaction of Viganext 500mg Sachet with other drugs
Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, nutritional supplements, and herbal products. Some medications, such as fampridine, can interact with Viganext 500mg Sachet and reduce its effectiveness or cause undesirable side effects.
More Information about Viganext 500mg Sachet
- Store Viganext 500mg Sachet at 30°C. Do not freeze the medicine.
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets.
- Always look for the expiration date before consuming it.
How to consume Viganext 500mg Sachet
Take Viganext 500mg Sachet exactly as prescribed by your physician. Follow the instructions provided by your healthcare professional. This medication is typically taken orally. Be sure to measure the correct dosage and mix it thoroughly before consuming. Your physician will determine the appropriate dosage and duration based on your age, body weight, and medical condition. Do not stop taking the medication unless advised by your doctor.
Safety Advices for Viganext 500mg Sachet
Pregnancy
Do not take Viganext 500mg Sachet unless recommended by your doctor. Inform your healthcare professional if you are pregnant, planning to become pregnant, or think you may be pregnant.
Breast Feeding
Breastfeeding while taking Viganext 500mg Sachet is not safe. Before starting treatment, inform your doctor if you are breastfeeding. For more information, please consult your doctor.
Lungs
It is not known whether Jolvig 500mg sachet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
It is unclear whether Viganext 500mg Sachet is safe for patients with liver problems. Please inform your physician if you have any liver disease before starting treatment. Contact your doctor if you experience any liver-related symptoms.
Alcohol
It is not known whether alcohol interacts with Viganext 500mg Sachet. Please inform your physician if you consume alcohol before starting the treatment.
Driving
Do not drive or operate machinery, as it may impair your ability. Consult your doctor for more information.
Side Effects
Side effects are unintended symptoms caused by medications. Although all drugs can cause side effects, not everyone experiences them.
Serious
- Visual changes
- Allergic reactions
- Restlessness
- Significant sedation
Common
- Tiredness
- Sleepiness
- Joint pain
- Headache
- Weight gain
- Tremor
- Numbness, tingling
- Pain
- Disturbance of concentration and memory
- Anaemia
- Speech problems
- Unusual hair loss
Word of Advice
Before starting treatment with Viganext 500mg Sachet, inform your doctor if you have any kidney-related conditions, as it is not known if this medicine is safe for patients with kidney issues. Follow the dosage and administration instructions provided by your healthcare professional. Make sure to inform your doctor about any known allergies or medical conditions you have. If you experience any unexpected or severe side effects, such as difficulty breathing or an allergic reaction, seek immediate medical attention. Additionally, let your healthcare professional know about any other medications or supplements you are taking to avoid potential drug interactions. For any concerns about the treatment, consult your healthcare professional for further information.
FAQs
Q 1. How can I manage side effects while taking Viganext 500mg Sachet?
If you experience any side effects while taking Viganext 500mg Sachet, make sure to stay hydrated by drinking plenty of fluids. Your healthcare professional may suggest over-the-counter or prescription medications to help manage your symptoms. Contact your physician if the side effects are severe or persistent.
Q 2. Are there any dietary restrictions while taking Viganext 500mg Sachet?
There are no specific dietary restrictions for Viganext 500mg Sachet. However, it is advisable to maintain a healthy and balanced diet to support overall health and well-being.
Q 3. How long does it take for Viganext 500mg Sachet to start working?
The time it takes for Viganext 500mg Sachet to start working can vary from person to person. It is important to continue taking the medication as prescribed by your healthcare provider to achieve the best treatment outcomes.
Fact Box of Viganext 500mg Sachet
Molecule name: Vigabatrin
Pharmacological class: Anticonvulsants
Therapeutic class: Antiepileptic agent
Indications:
1. Uncontrolled epilepsy
2. Infantile spasms
Reviews
There are no reviews yet.